Medicalization of female genital mutilation/cutting  by Serour, G.I.
African Journal of Urology (2013) 19, 145–149
Pan African Urological Surgeons’ Association
African  Journal  of  Urology
www.ees.elsevier.com/afju
www.sciencedirect.com
Review
Medicalization  of  female  genital  mutilation/cutting
G.I.  Serour a,b,1,∗
a International  Islamic  Center  for  Population  Studies  and  Research,  Al-Azhar  University,  Egypt
b Clinical  director,  the  Egyptian  IVF&ET  center,  Maadi,  Egypt
Received 1st November 2012; received in revised form 28 January 2013; accepted 28 January 2013
KEYWORDS
Genital Mutilation;
Medicalization;
Female
Abstract
Globally 100–140 million women and girls have been subjected to female genital mutilation/cutting
(FGM/C) which is a harmful practice, associated with immediate and long term complications, has no
benefit what so ever, is unethical and has no religious basis. Inspite of global efforts to eradicate FGM/C
every year 3 million girls are subjected to this harmful practice mostly in Africa and Asia.
In some countries FGM/C is increasingly performed by health-care providers, which is alarming. Medical-
ization of FGM/C is proposed by some health professionals to reduce the incidence of its complications.
However medicalization of FGM/C will not reduce the long term complications of FGM, has no benefit
what so ever, has no medical indication, and thus its performance violates the code of medical ethics. Fur-
thermore its medicalization would result in a setback in the global efforts to eradicate this harmful practice,
and will give the green light to its performance by non health-care providers with subsequent increased
incidence of complications.
In some Muslim countries where FGM/C is prevalent it is often wrongly quoted that the basis for performing
FGM/C is religious instruction. FGM/C has no religious basis what so ever and has been condemned by Al-
Azhar based on several verses in the Holy Quraan that relates explicitly or implicitly to female circumcision.
The use of the gender term “Sunna circumcision” is nothing but a form of deceit used to misguide people∗ Correspondence address: International Islamic Center for Population
Studies and Research, Al-Azhar University, Egypt. Tel.: +20 225755869;
fax: +20 225754271.
E-mail address: giserour1@link.net
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and give the impression that this act is one of the Islamic practices. As for the traditions attributed to Prophet
Mohamed (PBUH), scholars of the past and present have agreed that none of these traditions are authentic
and therefore should not be attributed to the Prophet (PBUH).
© 2013 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. 
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Open access under CC BY-NC-ND license.emale genital mutilation/cutting (FGM/C) comprises all proce-
ures that involve partial or total removal of female external
enitalia and/or injury to the female genital organs for cultural
r any other nontherapeutic reasons [1]. While the term “muti-
ation” reinforces the idea that this practice is a violation of the
uman rights of girls and women, at the community and indi-
idual levels the term can be problematic and offensive, and the
erm “cutting” may be more acceptable. FGM/C is practiced in
8 African countries and in some nations in Asia and the Mid-
le East. As a result of international migration, FGM/C is a global
roblem and is not limited to any cultural or religious groups [2].
he World Health Organization classifies FGM/C into 4 types,
arying in severity from partial or total removal of the clitoris
o extensive mutilation of the external genitalia [3]. The type
f FGM/C practiced varies within and between countries [1–4].
ccording to WHO modified typology, type III FGM/C – known
s infibulation – is narrowing of the vaginal orifice through the
reation of a covering seal formed by cutting and apposition of
he labia minora and/or the labia majora, with or without exci-
ion of the clitoris [3]. The term infibulation is derived from the
atin “fibula” meaning tightening of the vaginal introitus to leave
nly a very small opening for the flow of urine and menstrual
lood. Defibulation is an anterior midline vulval incision of the
car, commonly performed before gynecological operations, such
s cervical biopsy, evacuation colposcopy or, polypectomy, and
efore urological operation such as cystescopy, to allow access to
he female genital organs or the lower urinary tract through the
agina. It is also performed at the time of delivery or prenatally
o avoid acute problems at the time of delivery, such as obstructed
abour, vesicovaginal and rectovaginal fistulas, and laceration of the
car tissue which results in various obstetric complications such
s laceration of the perineum, maternal haemorrhage or perinatal
sphyxia.
esuturing of the vulva after delivery, gynecologicalor urological
rocedures of the incised scar tissue is knwon as reinfibulation.
ometimes what is locally interpreted as reinfibulation is also per-
ormed on women who have not been infibulated in the first place
5,6].
n estimated 91.5 million girls and women aged 10 years and older
ave been subjected to FGM/C in African countries where preva-
ence data is available [7]. The number of women who are likely
o have undergone reinfibulationis estimated to be around 6.5–10.4
illion women [6].
he prevalence of reinfibulation differs markedly in different
ountries. Reinfibulation is most prevalent in countries where type
II FGM/C is prevailing, such as Somalia (98–100%), Sudan (82%),
jibouti (50%), and Eritrea (34%). Reinfibulation is less prevalent in
ther countries where infibulation is rarely performed, such as Egypt
9%), Chad, Ethiopia, Kenya, and Nigeria, where infibulation is only
F
t
u
serformed in certain regions. It is less prevalent in Burkina Faso,
entral African Republic, Ivory Coast, Guinea, Liberia, Senegal,
ierra Leone, Cameron, Democratic Republic of Congo, Guinea-
issau, Mauritania, and Uganda where type I and type II FGM is
erformed [2–8]. Reinfibulation is occasionally performed among
mmigrants in Europe and North America even though FGMC is
rohibited in these countries [9].
espite efforts to abandon FGM/C, it is estimated that each year
pproximately 3 million girls in Africa alone are at risk of being
ubjected to FGM [10].
espite global strategy to stop health care providers from perform-
ng FGM it is still being performed by health care providers in many
arts of the world [5].
isks of  FGM/C  on  medical  grounds
GM/C is physically invasive, emotionally damaging, and is asso-
iated with complications that may seriously affect the reproductive
ealth of women and increase the risks for the unborn child. FGM/C
iolates human right to the highest attainable standard of health and
o bodily integrity [11].
GM/C is associated with the potentials of localized infection or
bscess formation, septicemia, tetanus, hemorrhage, shock, death,
cute retention of urine, and contraction of hepatitis and/or HIV
articularly when it is performed in non sterile settings [1–3].
lthough the medicalization of FGM/C may reduce the incidence
f these acute complications, it has no effect on the incidence of
ate gynecological and obstetric complications. The gynecological
omplications of FGM/C include sexual dysfunction, apareunia,
uperficial dyspareunia, chronic pain, scar formation, dysmenor-
hea, vaginal laceration during sexual intercourse, difficulty passing
rine, and difficulty during gynecological or urological examination
nd procedures [2].
 multicenteric study by WHO had shown that there are increased
elative risks for cesarean delivery (RR 1.31), postpartum hemor-
hage (RR 1.69), extended maternal hospital stay (RR 1.98), infant
esuscitation (RR 1.66), and stillbirth or early neonatal death (RR
.55) [12]. Justification for performing FGC/M appears to be a
eeply rooted and ancient custom. The practice of this custom in
ncient Egypt was reported by Herodotus (500 B.C.) and Strabo,
he Greek geographer. Herodotus reported 500 years BC that female
ircumcision was practiced by Phoenicians, Hittites, Ethiopians as
ell as the Egyptians.GM is mostly performed to emphasize a cultural identity. Cus-
om and tradition are by far the most frequently cited reasons for
ndergoing FGM and often perpetuated by older women who were
ubjected to FGM.
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In a FGM practicing society a girl cannot be considered as an adult,
unless she has undergone FGM. It is done because it always has been
done. It is also performed to identify a gender identity. For a girl to
be considered a complete woman FGM is often deemed necessary.
FGM marks the divergence of the sexes concerning their roles in
life and marriage. FGM is supported by the widespread belief that
the human body is androgynous at birth. To ensure adulthood, girls
must be relieved of their male part, the clitoris and or/labia [13].
Excision of such parts of a woman’s body is thought to enhance the
girl’s feminity.
FGC/M is also performed with the wrong assumption that it controls
women’s sexuality and reproductive functions and reduces women’s
desire for sex.
One of the reasons given to support FGM in some cultures is
enhancement of the man’s sexual pleasure [14–17].
Cleanliness and hygiene are frequently quoted as justifications
for FGM. Terms for mutilation are synonymous with purification
(Tahara (Egypt), Tuhara (Sudan), Sili-ji (Bambarra in Mali).
Circumcision is also quoted to promote virginity and chastity and
guards young girls from sexual frustration by deadening their sexual
desire.
FGC/M and  informed  consent
FGM/C is a surgical procedure and the code of medical ethics
necessitates obtaining free informed consent from the patient before
performing the procedure. The majority FMC/M procedures are
performed on girls between ages of 4 and 14 years or sometimes
young infants. All these victims are non capable of autonomy and
consequently cannot give their free informed consent. Even when
FGM/C is performed on adult women they are not included in the
decision making process and the midwife and female relatives are
usually behind the decision to perform reinfibulation. This may pro-
tect them from being deserted or divorced by their husbands. Lack
of women’s rights and economic dependence on men influences a
woman’s acceptance of reinfibulation.
Who performs  FGC/M,  when,  where,  and  why?
While FGC/M is usually performed by traditional healers, barbers
or dayas on young girls or infants reinfibulation is usually performed
by doctors or midwives between 2 h and 40 days after delivery. It
may also be performed following gynaecological or urological oper-
ations on the vagina, cervix, uterus urethra and bladder. A worrying
trend is that, FGM/C is increasingly performed by health profes-
sionals [6]. They claim that they are fulfilling the cultural demands
of the community, enhancement of women’s value in the society,
and respecting patients’ cultural rights since some of those making
the decisions are of mature age and capable of autonomy [17–19].
However, the real reason is that it is a source of income for those
who perform it; the fees are high, especially in countries where it is
illegal.It is also argued that when the procedure is performed by health care
providers the incidence of complications is significantly reduced
but not eliminated. It is often quoted that women who undergo
reinfibulation are adult consenting women who are fully capable
o
a
u
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f autonomy. The analogy of consenting women undergoing body
iercing procedures and cosmetic surgery is often used. However,
n body piercing and cosmetic surgery the woman is counseled and
ives her informed consent, which she can withdraw at any time
efore the procedure. In contrast, women who undergo reinfibu-
ation are not usually included in the decision-making process or
rovided with the information that enables them to make a freely-
nformed consenting decision [6]. A woman may perceive that
osmetic procedures have some benefits, and the procedures are
ypically performed only after careful consideration of their impli-
ations [1–12].
 health professional performing FGC/M or reinfibulation has a
onflict of interest. While he/she should advise the guardian of the
emale child or women against FGM/C and reinfibulation, based on
ts risks, best medical practice evidence and medical ethics, it is in
is/her best interest to perform FGM/C or reinfibulation for personal
nancial gain.
edicalization  of  FGM/C
 joint technical consultation on the medicalization of FGM/C held
y WHO, UNICEF, and UNFPA in Nairobi, Kenya, from 20 to 22
uly, 2009, condemned the practice of female genital cutting by
edical professionals in any setting, including hospitals and other
ealth establishments. Demographic and Health Surveys data show
hat the medicalization of FGM/C has increased substantially in
ecent years, particularly in Egypt, Guinea, Kenya, Nigeria, North-
rn Sudan, Mali, and Yemen and recently in Indonesia. In many
f these countries one-third or more of women had their daugh-
ers cut by a trained health professional. An increased number of
ounger compared with older women are undergoing FGM/C by
edical personnel, demonstrating a trend toward the practice [10].
here are various arguments made by medical doctors who excise
omen and girls. Some believe that FGM/C including reinfibula-
ion is a medical necessity; others argue that performing FGM/C
nder sanitary conditions reduces its risks; while others consider
heir personal economic benefits. Sadly medicalization of various
orms of FGM/C including reinfibulation has been supported by
ome international humanitarian organizations, professional orga-
izations and governments. In 1994, the Egyptian minister of health
tated that doctors could perform FGM/C on girls in designated
acilities at fixed times and prices, claiming that medicalization of
he practice would reduce complications and eventually end the
ractice [20]. Subsequent pressure from international agencies, as
ell as the reported deaths of girls who were cut in hospitals, insti-
ated a renewed ban on the practice in public hospitals in Egypt
10].
n 1999, the international medical aid agency, Medicines Sans
rontiers (MSF), said its workers provided surgical equipment
or FGM/C, but claimed it did not support the procedure. MSF
rgued that providing clean instruments was a “first aid response,”
ince female genital mutilation can result in infections and cause
horrific complications” in childbirth and during intercourse [21].
ollowing public condemnation by advocacy groups, MSF issued a
olicy paper in the same year opposing female genital cutting. The
rganization stated that the procedure would not be undertaken in
ny of its facilities and that instruments it supplied would not be
sed for the procedure [21]. In 2010, The American Academy of
ediatrics organization in the USA recommended to its members
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erforming minor forms of FGM/C for girls to maintain the
raditions and customs for some communities in the USA. The
nternational Federation of Obstetrics and Gynecology (FIGO)
mmediately responded by the following statement:
rofessor GamalSerour – FIGO President – is deeply concerned and
larmed at the terrible news that has recently surfaced supporting
edicalisation of some forms of Female Genital Mutilation/Cutting
FGM/C). FIGO–an international Federation embracing 124 mem-
er societies of obstetricians and gynecologists in the developed
nd developing world–strongly condemns all forms of FGM/C, per-
ormed by traditional or medical personnel in all countries and all
ommunities around the globe, as they are harmful, unethical, with
o benefits whatsoever, and are against the code of medical practice.
IGO strongly condemns all past, present or future calls to medi-
alise any form of FGM/C. FIGO affirms its firm stance on this issue
s outlined in its previous resolution, guidelines, publications and
onjoint statements. FIGO welcomes the withdrawal of the deci-
ion of the few organisations who issued or considered the issue of
tatements implying the support of any form of FGM/C.
he professional organization in USA responded to the Plea of FIGO
nd the pressure of many Humanitarian groups by withdrawing its
ecommendation. In 2011, the MOH of one government in Asia
ssued its clinical guideline on FGC/M to be performed by health
rofessionals in hospitals. The rationale behind these regulations –
hat when conducted by a qualified healthcare professional, under
terile conditions, the procedure is a safer option than if it were
o be carried out by a traditional healer. The MOH argument was
hat this first contact presents doctors, midwives and nurses with
he opportunity to counsel mothers about the futility of the pro-
edure, thereby discouraging future practice. On December 14th,
011, FIGO responded by a communicé to the MOH stating that
he fundamental issue that FIGO President has with the guidelines
s that it legitimises a procedure which has no known medical or
ealth benefit. This places pressure on healthcare workers to be
nvolved in a ritual practice which they may be professionally and/or
orally opposed to. Urging MOH to visit FIGO Ethical Guidelines
n FGM at www.figo.org. FIGO’s President highlighted that the
ecent MOH guidelines call for the medicalization of FGM con-
ravenes the principles in the previous UN and WHO resolutions
nd statement signed by member countries. They are a retrograde
tep. Egypt has gone before through the same path and legalized
edicalization of FGM. However after a short period of practice,
ittle mortality occurred from FGM performed by doctors in hospi-
als. Consequently, the government of Egypt banned the procedure
otally. Implementation of the national guidelines is a clear signal
o other countries that female circumcision is an acceptable form of
GM. The good work that has been done to eradicate the practice
ver the past two decades will be in jeopardy. The author as the
irector of the International Islamic Center for Population Studies
nd Research (IICPSR), Al-Azhar University has pointed out to the
OH that (IICPSR) dealt with the issue in its book titled “Chil-
ren in Islam: their care, upbringing and protection”, published by
he Al Azhar University in cooperation with UNICEF 2005, and
ondemned medicalization of FGM/C www.unicef.org, p: 61–62
22].GM/C is an extreme example of discrimination based on sex
s a way to control women’s sexuality. FGM/C denies girls and
omen full enjoyment of their personal, physical, and psycho-
ogical integrity, rights, and liberties. FGM/C is an irreparable,G.I. Serour
rreversible abuse of the female child. It violates girls’ “right to the
njoyment of the highest attainable standard of health and to protec-
ion,” contrary to the ethical principles of beneficence, justice, and
on-maleficence. Health professionals who support the practice are
ontravening the medical code of ethics to “do no harm.” Educating
he public, members of the health profession and practitioners of tra-
itional health care, community leaders, educators, social scientists,
uman rights activists, and others who implement policies is neces-
ary to trigger awareness of the extent of the problem and the dangers
f medicalization of all types of FGM/C, including reinfibulation.
he medicalization of all types of FGM/C should be condemned
t national and international levels. It is the duty of professional
odies and organizations to advise members and all health workers
ot to undertake FGM/C, including reinfibulation, and to hold them
ccountable for this unethical practice. We need a concerted effort
nd collaboration of UN agencies, world professional organizations,
nd their member societies including obstetricians, midwives, and
ediatricians. These agencies and bodies must be supported by the
ommitments of governments, politicians, parliamentarians, legis-
ators, mass media, religious leaders, and NGOs.
omen who have been infibulated should be counseled with their
pouses about the harmful effects of reinfibulation during prenatal
are whenever possible to encourage them not to undergo reinfibu-
ation after childbirth. Women of all ages who have been subjected
o infibulation should be treated at all stages, including pregnancy
nd childbirth, with sympathy, respect, and medically evidence-
ased care. Depending on local laws, properly informed women who
ave been infibulated and who, following childbirth, independently
equest resuturing, should be treated carefully. The practitioner
hould explain the benefits of unsuturing and advise the patient on
he immediate and long-term complications of reinfibulation. The
ractitioner should also emphasize that all FGM/C procedures are
rofessionally condemned [11].
n conclusion, the medicalization of FGM/C, including reinfibu-
ation, although it may reduce the immediate health hazards of
he procedure, underestimates its overall physical and psychologi-
al complications. Medicalization of all forms of FGM/C violates
uman rights, ethical principles of justice, beneficence and non mal-
ficience and the medical code of ethics. It creates tacit approval
hat only propels this harmful cultural behavior, rather than tacit
isapproval and encouragement to change the behavior.
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